Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...

Hundreds of Americans have filed lawsuits in multiple states against pharmaceutical giants Novo Nordisk and Eli Lilly, ...

Stocks to Watch. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are archrivals thanks to their dueling drugs for weight loss, Zepbound and ...

Fleming, who admittedly discovered penicillin by chance, is reported to have said, “When I woke up just after dawn on ...

The market could potentially see the emergence of new biotech industry leaders. Since the year started, Viking Therapeutics ...

The controversy surrounding Ozempic, a popular diabetes medication turned weight-loss solution, has exploded as victims of severe side effects unite to file lawsuits against its manufacturers, Novo ...

Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Read more here.

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Agios Pharma (AGIO – Research Report) yesterday and set a ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.